Investors may be wondering whether Moderna's current share price reflects its true value, or if the market is still trying to ...

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday morning. Here’s what you need to know.

Leerink raised the firm’s price target on Moderna (MRNA) to $18 from $15 and keeps an Underperform rating on the shares following the company’s annual Investor Day, where it provided a commercial and ...

Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses to the US.